Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Yilitai Technology is a Chinese medical technology company specializing in the In Vitro Diagnostics (IVD) sector. The company focuses on the development, production, and distribution of automated chemiluminescence immunoassay (CLIA) systems and Point-of-Care Testing (POCT) solutions. Their product portfolio includes high-performance analyzers and a wide range of diagnostic reagents for cardiac markers, inflammatory markers, and infectious diseases. Yilitai aims to provide clinical laboratories and hospitals with efficient, high-sensitivity diagnostic platforms that improve patient care. Based in Shenzhen, the company continues to invest in R&D to advance its proprietary diagnostic technologies for the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yilitai Technology.